Loading insider details...
Latest Form 4 (Sep 22, 2026): Exercise/Conversion of 7,438 MLYS shares, $98.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 7,438 | $98.5K |
| Aug 25, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 7,437 | $98.5K |
| Jul 23, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 7,438 | $98.5K |
| Jun 30, 2026 | Mineralys Therapeutics, Inc. (MLYS) | Exercise/Conversion | 104,124 | $1.38M |
| Apr 21, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 108 | $105.62 |
| Mar 19, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 2,433 | $3.6K |
| Mar 17, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 213,000 | n/a |
| Feb 20, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 239 | $446.45 |
| Jan 21, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 123 | $277.98 |
| Dec 18, 2024 | Esperion Therapeutics, Inc. (ESPR) | Sale | 2,234 | $5.4K |